PJSC Pharmstandard (LSE: PHST IL, ÌÎÅÕ: PHST RU) (hereinafter the "Company" or "Pharmstandard") announces the receipt of notification on execution of mandatory tender offer.

On September 14, 2016 the Company has been notified by Augment Investments Limited, its controlling shareholder, that under Russian law governed mandatory tender offer Augment Investments Limited acquired for cash 4,538,675 ordinary shares of the Company from the remaining shareholders.

As a result, Augment Investments Limited together with its affiliate OJSC “Pharmstandard-Leksredsvta” holds 37,081,092 ordinary shares, which represents 98.117% of totally issued ordinary shares of the Company.